1 results  1 of 1 

1 A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
Jung-Yun Lee, Jae Weon Kim, Myong Cheol Lim, Sunghoon Kim, Hee Seung Kim, Chel Hun Choi, Ju Yeon Yi, Sang-Yoon Park, Byoung-Gie Kim,
J Gynecol Oncol.2019;30(6):e112.  Published online 2019 September 3     DOI: http://dx.doi.org/10.3802/jgo.2019.30.e112
      

 1 of 1